WallStreetZenWallStreetZen

NYSE: DVA
Davita Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Davita earnings were $859.6M for the trailing 12 months ending Mar 31, 2025, with 14% growth year over year. The latest DVA earnings report on Mar 31, 2025 announced Q1 2025 earnings of $162.9M, down 37.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DVA reported annual earnings of $936.3M, with 35.4% growth. The next DVA earnings date is Aug 5, 2025.

DVA past earnings growth

How has DVA's earnings growth performed historically?

Company
14.02%
Industry
12.81%
Market
36.02%
DVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DVA's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DVA earnings history

Current Revenue
$13.0B
Current Earnings
$859.6M
Current Profit Margin
6.6%
DVA's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

DVA Return on Equity

Current Company
393.6%
Current Industry
-68%
Current Market
31.3%
DVA's Return on Equity (393.6%)... subscribe to Premium to read more.
High Return on Equity Performance

DVA undefined

Current Company
5%
Current Industry
6.8%
DVA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DVA announces earnings.

DVA undefined

Current Company
11.49%
Current Industry
14.3%
DVA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DVA vs Medical Care Facility Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DVA$2.35B$859.61M+10.43%$10.33
EHC$1.25B$654.30M+7.07%$4.91
UHS$2.33B$1.20B+17.17%$18.13
ENSG$526.18M$322.80M+17.42%$5.67
THC$3.70B$1.48B+40.24%$15.86
View Top Medical Care Facility Stocks

DVA earnings dates

Next earnings date
Aug 5, 2025

Davita Earnings Reports & History FAQ

What were Davita's earnings last quarter?

On DVA's earnings call on Invalid Date, Davita (NYSE: DVA) reported Q1 2025 earnings per share (EPS) of $2.05, up 24.91% year over year. Total DVA earnings for the quarter were $162.92 million. In the same quarter last year, Davita's earnings per share (EPS) was $2.73.

If you're new to stock investing, here's how to buy Davita stock.

When does Davita report earnings?

The next DVA earnings call is Invalid Date. Add DVA to your watchlist to be reminded of Davita's next earnings date.

Is Davita profitable or losing money?

As of the last Davita earnings report, Davita is currently profitable. Davita's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $859.61 million, a 5.39% increase year over year.

What was DVA's earnings growth in the past year?

As of Davita's earnings date in Invalid Date, Davita's earnings has grown 14.02% year over year. This is 1.2 percentage points higher than the US Medical Care Facilities industry earnings growth rate of 12.81%. DVA earnings in the past year totalled $859.61 million.

What are Davita's earnings expectations?

The current EPS estimate for Davita's earnings report in Invalid Date is $2.78.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.